Seres Therapeutics, Nestlé Health Science Announce SER-109 Co-Commercialization License Agreement
Seres Therapeutics, Inc. announced that it has entered into an agreement with Nestlé Health Science to jointly commercialize SER-109, Seres’ investigational oral microbiome therapeutic…
Read More...
Read More...
